News Articles Tagged: Thrombocytopenia Management

The Role of Lusutrombopag (CAS 1110766-97-6) in Modern Thrombocytopenia Therapies

Explore the therapeutic significance of Lusutrombopag (CAS 1110766-97-6) as a TPO receptor agonist in treating thrombocytopenia. NINGBO INNO PHARMCHEM offers this vital API for research and pharmaceutical manufacturing.

Avatrombopag Maleate: Navigating Treatment Options for Immune Thrombocytopenia and Chronic Liver Disease

NINGBO INNO PHARMCHEM CO.,LTD. provides insights into Avatrombopag Maleate as a key treatment for ITP and thrombocytopenia in CLD patients.